tue: fujifilm technologies potential global roll—out here?e one in the us as well which is its sister plant, and i believe there are discussions under way for rolling this out as a us vaccine. but certainly there is no reason — there's plenty of land there, plenty of opportunity to build the facility out, and there's no reason why they couldn't export the vaccine. but that's notjust couldn't export the vaccine. but that's not just what they do at this plant, they manufacture all kinds of pharmaceuticals and medication and do research. and of course, we've got the national biological institute here as well. so you can certainly see the potential for a huge boost in pharma for this area. we wish you all the very best, which will be an incredibly busy time over the next few months. thank you so much, rachel. it's also important to note that the uk has secured 60 million doses of the novavax jab, so we will follow the approval of that very closely and keep you updated. so what's the situation with some of the key vaccines? nine have been authoris